Italian medical device vendor Esaote posted increased revenues for fiscal year 2023, citing upticks in sales in its ultrasound and MRI segments.
Financial results for the company's full fiscal year (end-December 31) showed revenues of 273.2 million euros ($292 million), up 6.5% over fiscal year 2022.
Sales increased in all business lines, especially in the ultrasound segment (9.7%), driven by the launch in early 2023 of its MyLabTMX90 cart system, Esaote said. The company’s MRI sector was up 3.3% over fiscal year 2022, driven by sales of its Magnifico Open "total-body" open magnet system.
The company reported a consolidated net profit of 6.2 million euros ($6.6 million), up from 1.2 million euros ($1.3 million) in 2022.
